APG Asset Management
MRNA icon

APG Asset Management’s Moderna MRNA Stock Holding History

APG Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-219,400
Closed -$4.82M – 556
2025
Q3 		$4.82M Buy
219,400
+3,700
+2% +$103K 0.01% 449
2025
Q2 		$5.07M Sell
215,700
-2,300
-1% -$60.6K 0.02% 449
2025
Q1 		$5.72M Sell
218,000
-9,819
-4% -$348K 0.02% 438
2024
Q4 		$9.15M Buy
227,819
+203,792
+848% +$9.74M 0.03% 384
2024
Q3 		$1.44M Sell
24,027
-198,606
-89% -$18.2M 0.01% 344
2024
Q2 		$24.7M Buy
222,633
+26,300
+13% +$3.33M 0.04% 309
2024
Q1 		$19.4M Sell
196,333
-44,339
-18% -$4.47M 0.03% 345
2023
Q4 		$21.7M Sell
240,672
-10,807
-4% -$909K 0.04% 318
2023
Q3 		$26M Sell
251,479
-34,816
-12% -$3.88M 0.05% 295
2023
Q2 		$31.9M Sell
286,295
-5,857
-2% -$781K 0.06% 276
2023
Q1 		$41.3M Sell
292,152
-54,712
-16% -$9.03M 0.09% 242
2022
Q4 		$62.3M Buy
346,864
+229,928
+197% +$37.6M 0.12% 199
2022
Q3 		$14.1M Buy
116,936
+35,908
+44% +$5.45M 0.04% 350
2022
Q2 		$11.1M Sell
81,028
-23,839
-23% -$3.41M 0.03% 384
2022
Q1 		$16.2M Buy
104,867
+13,137
+14% +$2.21M 0.03% 379
2021
Q4 		$20.5M Sell
91,730
-179,937
-66% -$52.6M 0.03% 368
2021
Q3 		$90.2M Buy
271,667
+10,600
+4% +$3.91M 0.16% 155
2021
Q2 		$51.7M Buy
261,067
+193,600
+287% +$34.6M 0.09% 259
2021
Q1 		$7.52M Sell
67,467
-431,580
-86% -$62.5M 0.01% 516
2020
Q4 		$42.6M Buy
499,047
+13,577
+3% +$1.37M 0.07% 288
2020
Q3 		$29.3M Buy
485,470
+166,145
+52% +$11.6M 0.05% 347
2020
Q2 		$18.3M Buy
+319,325
New +$17.5M 0.03% 428

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

APG Asset Management's MRNA Position: Q4 2025 in Review

APG Asset Management sold out of Moderna (MRNA) in Q4 2025, closing a stake of 219,400 shares — an estimated $4.82M sold.

APG Asset Management first reported a position in MRNA in Q2 2020 and held it in 22 quarters. The position peaked at $90.2M in Q3 2021. 673 funds tracked by Wall St. Rank hold MRNA as of Q4 2025.

  • APG Asset Management reported no remaining Moderna position as of Q4 2025 after selling out during the quarter.
  • APG Asset Management sold 219,400 Moderna shares in Q4 2025, an estimated $4.82M.
  • APG Asset Management first reported a position in Moderna in Q2 2020 and held it in 22 quarters.
  • APG Asset Management's Moderna position peaked at $90.2M in Q3 2021.
  • 673 funds tracked by Wall St. Rank held Moderna as of Q4 2025.

Based on APG Asset Management's 13F filing for Q4 2025, filed 12 Feb 2026.